| ticlopidine | <chemical> 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine. Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis. Pharmacological action: fibrinolytic agent, platelet aggregation inhibitors. Chemical name: Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro- (12 Dec 1998) |
|---|---|
| DRG | <abbreviation> Diagnosis-related group. (05 Mar 2000) |
| outliers, drg | In health care reimbursement, especially in the prospective payment system, those patients who require an unusually long hospital stay or whose stay generates unusually high costs. (12 Dec 1998) |